Roser M, Ritchie H. Cancer. Our World Data [Internet]. 2015 Jul 3 [cited 2021 Sep 13]; Available from: https://ourworldindata.org/cancer
Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112(S11):2577–92. https://doi.org/10.1002/cncr.23448.
Parsons HM, Harlan LC, Lynch CF, Hamilton AS, Wu XC, Kato I, et al. Impact of cancer on work and education among adolescent and young adult cancer survivors. J Clin Oncol. 2012;30(19):2393–400. https://doi.org/10.1200/JCO.2011.39.6333.
Article PubMed PubMed Central Google Scholar
Clarke TC, Christ SL, Soler-Vila H, Lee DJ, Arheart KL, Prado G, et al. Working with cancer: health and employment among cancer survivors. Ann Epidemiol. 2015;25(11):832–8. https://doi.org/10.1016/j.annepidem.2015.07.011.
Article PubMed PubMed Central Google Scholar
Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77(2):109–30. https://doi.org/10.1016/j.critrevonc.2010.01.004.
Drolet M, Maunsell E, Brisson J, Brisson C, Mâsse B, Deschênes L. Not working 3 years after breast cancer: predictors in a population-based study. J Clin Oncol. 2005;23(33):8305–12. https://doi.org/10.1200/JCO.2005.09.500.
Lee MK, Lee KM, Bae JM, Kim S, Kim YW, Ryu KW, et al. Employment status and work-related difficulties in stomach cancer survivors compared with the general population. Br J Cancer. 2008;98(4):708–15. https://doi.org/10.1038/sj.bjc.6604236.
Article CAS PubMed PubMed Central Google Scholar
Syse A, Tretli S, Kravdal Ø. Cancer’s impact on employment and earnings—a population-based study from Norway. J Cancer Surviv. 2008;2(3):149–58. https://doi.org/10.1007/s11764-008-0053-2.
Taskila-Brandt T, Martikainen R, Virtanen SV, Pukkala E, Hietanen P, Lindbohm ML. The impact of education and occupation on the employment status of cancer survivors. Eur J Cancer Oxf Engl 1990. 2004;40(16):2488–93. https://doi.org/10.1016/j.ejca.2004.06.031.
Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003;58(1):82–91. https://doi.org/10.1093/gerona/58.1.m82.
Bradley CJ, Neumark D, Luo Z, Bednarek H, Schenk M. Employment outcomes of men treated for prostate cancer. J Natl Cancer Inst. 2005;97(13):958–65. https://doi.org/10.1093/jnci/dji171.
Carlsen K, Oksbjerg Dalton S, Frederiksen K, Diderichsen F, Johansen C. Cancer and the risk for taking early retirement pension: a Danish cohort study. Scand J Public Health. 2008;36(2):117–25. https://doi.org/10.1177/1403494807085192.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. https://doi.org/10.3322/caac.21254.
Favier O, Heutte N, Stamatoullas-Bastard A, Carde P, Van’t Veer MB, Aleman BMP, et al. Survival after Hodgkin lymphoma: causes of death and excess mortality in patients treated in 8 consecutive trials. Cancer. 2009;115(8):1680–91. https://doi.org/10.1002/cncr.24178.
Joly F, Henry-Amar M, Arveux P, Reman O, Tanguy A, Peny AM, et al. Late psychosocial sequelae in Hodgkin’s disease survivors: a French population-based case-control study. J Clin Oncol. 1996;14(9):2444–53. https://doi.org/10.1200/JCO.1996.14.9.2444.
Article CAS PubMed Google Scholar
Chen AB, Feng Y, Neuberg D, Recklitis C, Diller LR, Mauch PN, et al. Employment and insurance in survivors of Hodgkin lymphoma and their siblings: a questionnaire study. Leuk Lymphoma. 2012;53(8):1474–80. https://doi.org/10.3109/10428194.2012.660629.
Wettergren L, Björkholm M, Axdorph U, Bowling A, Langius-Eklöf A. Individual quality of life in long-term survivors of Hodgkin’s lymphoma–a comparative study. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2003;12(5):545–54. https://doi.org/10.1023/a:1025024008139.
Pálmarsdóttir R, KiesbyeØvlisen A, Severinsen MT, Glimelius I, Smedby KE, El-Galaly T. Socioeconomic impact of Hodgkin lymphoma in adult patients: a systematic literature review. Leuk Lymphoma. 2019;60(13):3116–31. https://doi.org/10.1080/10428194.2019.1613538.
Abrahamsen AF, Loge JH, Hannisdal E, Holte H, Kvaløy S. Socio-medical situation for long-term survivors of Hodgkin’s disease: a survey of 459 patients treated at one institution. Eur J Cancer. 1998;34(12):1865–70. https://doi.org/10.1016/S0959-8049(98)00269-X.
Article CAS PubMed Google Scholar
Aleman BMP, Raemaekers JMM, Tirelli U, Bortolus R, van’tVeer MB, Lybeert MLM, et al. Involved-field radiotherapy for advanced Hodgkin’s lymphoma. N Engl J Med. 2003;348(24):2396–406. https://doi.org/10.1056/NEJMoa022628.
Carde P, Burgers JM, Henry-Amar M, Hayat M, Sizoo W, Van der Schueren E, et al. Clinical stages I and II Hodgkin’s disease: a specifically tailored therapy according to prognostic factors. J Clin Oncol Off J Am Soc Clin Oncol. 1988;6(2):239–52. https://doi.org/10.1200/JCO.1988.6.2.239.
Carde P, Hagenbeek A, Hayat M, Monconduit M, Thomas J, Burgers MJ, et al. Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin’s disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol Off J Am Soc Clin Oncol. 1993;11(11):2258–72. https://doi.org/10.1200/JCO.1993.11.11.2258.
Noordijk EM, Carde P, Dupouy N, Hagenbeek A, Krol ADG, Kluin-Nelemans JC, et al. Combined-modality therapy for clinical stage I or II Hodgkin’s lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(19):3128–35. https://doi.org/10.1200/JCO.2005.05.2746.
Somers R, Carde P, Tarayre M, Thomas J, Hagenbeek A, Monconduit M, et al. A randomized study in stage IIIB and IV Hodgkin’s disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: A European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie cont. Henry-amar M, editor. J Clin Oncol. 1994;12–279; https://doi.org/10.1200/JCO.1994.12.2.279
Tubiana M, Henry-Amar M, Hayat M, Breur K, van der Werf-Messing B, Burgers M. Long-term results of the E.O.R.T.C. randomized study of irradiation and vinblastine in clinical stages I and II of Hodgkin’s disease. Eur J Cancer. 1979;15(5):645–57. https://doi.org/10.1016/0014-2964(79)90138-5.
Tubiana M, Hayat M, Henry-Amar M, Breur K, van der Werf Messing B, Burgers M. Five-year results of the E.O.R.T.C. randomized study of splenectomy and spleen irradiation in clinical stages I and II of Hodgkin’s disease. Eur J Cancer. 1981;17(3):355–63. https://doi.org/10.1016/0014-2964(81)90128-6.
Thomas J, Fermé C, Noordijk EM, Morschhauser F, Girinsky T, Gaillard I, et al. Comparison of 36 Gy, 20 Gy, or no radiation therapy After 6 cycles of EBVP chemotherapy and complete remission in early-stage Hodgkin lymphoma without risk factors: results of the EORT-GELA H9-F Intergroup Randomized Trial. Int J Radiat Oncol. 2018;100(5):1133–45. https://doi.org/10.1016/j.ijrobp.2017.10.015.
Fermé C, Thomas J, Brice P, Casasnovas O, Vranovsky A, Bologna S, et al. ABVD or BEACOPP baseline along with involved-field radiotherapy in early-stage Hodgkin lymphoma with risk factors: results of the European Organisation for Research and Treatment of Cancer (EORTC)–Groupe d’Étude des Lymphomes de l’Adulte (GELA) H9-U intergroup randomised trial. Eur J Cancer. 2017 Aug;81:45–55; https://doi.org/10.1016/j.ejca.2017.05.005
Fermé C, Eghbali H, Meerwaldt JH, Rieux C, Bosq J, Berger F, et al. Chemotherapy plus involved-field radiation in early-stage Hodgkin’s disease. N Engl J Med. 2007;357(19):1916–27. https://doi.org/10.1056/NEJMoa064601.
van der Kaaij MAE, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser LC, et al. Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study. J Clin Oncol. 2012;30(31):3854–63. https://doi.org/10.1200/JCO.2011.40.8906.
van der Kaaij MAE, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, et al. Premature ovarian failure and fertility in long-term survivors of Hodgkin’s lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d’Etude des Lymphomes de l’Adulte Cohort Study. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(3):291–9. https://doi.org/10.1200/JCO.2011.37.1989.
van der Kaaij MAE, Heutte N, Le Stang N, Raemaekers JMM, Simons AHM, Carde P, et al. Gonadal function in males after chemotherapy for early-stage Hodgkin’s lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25(19):2825–32. https://doi.org/10.1200/JCO.2006.10.2020.
van der Kaaij MAE, van Echten-Arends J, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, et al. Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study. Hum Reprod Oxf Engl. 2014;29(3):525–33. https://doi.org/10.1093/humrep/det430.
Maraldo MV, Giusti F, Vogelius IR, Lundemann M, van der Kaaij MAE, Ramadan S, et al. Cardiovascular disease after treatment for Hodgkin’s lymphoma: an analysis of nine collaborative EORTC-LYSA trials. Lancet Haematol. 2015;2(11):e492-502. https://doi.org/10.1016/S2352-3026(15)00153-2.
Busson R, van der Kaaij M, Mounier N, Aleman BMP, Thiéblemont C, Stamatoullas A, et al. Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study. Health Qual Life Outcomes. 2019 Jul 2;17:115; https://doi.org/10.1186/s12955-019-1186-x
Home - Eurostat [Internet]. [cited 2021 Mar 28]. Available from: https://ec.europa.eu/eurostat
Fobair P, Hoppe RT, Bloom J, Cox R, Varghese A, Spiegel D. Psychosocial problems among survivors of Hodgkin’s disease. J Clin Oncol. 1986;4(5):805–14. https://doi.org/10.1200/JCO.1986.4.5.805.
Article CAS PubMed Google Scholar
Taskila T, Lindbohm ML. Factors affecting cancer survivors’ employment and work ability. Acta Oncol. 2007;46(4):446–51. https://doi.org/10.1080/02841860701355048.
留言 (0)